Neuren Pharmaceuticals Reports Strong Recovery and Focus on Innovative Treatments
Neuren Pharmaceuticals Ltd. has reported a significant recovery in its stock price and market capitalization, driven by investor confidence in its growth potential and ongoing research efforts in neurological and metabolic disorders.
2 minutes to read